Evidence map›Paper›PMID 24323343›Full record

SynthesisEuropean journal of pediatrics2014

Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children.

Shan Li, Xiu-li Huang, Jing-zhe Sui, Si-yuan Chen, Yan-tong Xie, Yan Deng, Jian Wang, Li Xie, Tai-jie Li, Yu He and 3 more

Abstract readMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in European journal of pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. [Clinical effects of different therapeutic regimens for Helicobacter pylori infection in children].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2017
    Trial
  8. Trial
  9. Trial
  10. Journal of biosciences · 2024
    Article
  11. Paediatrics & child health · 2022
    Review
  12. Paediatrics & child health · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Effect of Saccharomyces boulardii CNCM I-745 as complementary treatment of Helicobacter pylori infection on gut microbiome.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  18. Diagnosis and treatment ofChronic diseases and translational medicine · 2019
    Review
  19. Frontiers in cellular and infection microbiology · 2019
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Shan LiDepartment of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xiu-li Huang
Jing-zhe Sui
Si-yuan Chen
Yan-tong Xie
Yan Deng
Jian Wang
Li Xie
Tai-jie Li
Yu He
Qi-liu Peng
Xue Qin
Zhi-yu Zeng
Guangxi Medical University · CNFirst Affiliated Hospital of GuangXi Medical University · CNGuangxi University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe efficacy of probiotics supplementation in children undergoing Helicobacter pylori (H. pylori) eradication therapy remains controversial. This study aimed to meta-analyze whether probiotics supplementation in triple therapy could improve H. pylori eradication rates and reduce therapy-related side effects in children. Electronic databases PubMed and Embase were searched to identify all randomized controlled trials in pediatric patients comparing probiotics supplementation with placebo or no extra intervention in H. pylori eradication therapy. Two authors independently extracted the data. Results were expressed as odds ratios (ORs) and accompanying 95 % confidence intervals (CIs). Stata version 12.0 was used to perform all statistical analyses. Seven studies consisting of 508 pediatric patients were included in our study. The pooled ORs (studies n = 7) of eradication rates by intention-to-treat and per-protocol analysis in the probiotics group versus the control group were 1.96 (95 % CI 1.28-3.02) and 2.25 (95 % CI 1.41-3.57), respectively. The pooled OR (studies n = 5) of incidence of total side effects was 0.32 (95 % CI 0.13-0.79), with significant heterogeneity observed (I (2) = 71.9 %).

conclusionProbiotics supplementation in triple therapy for H. pylori infection may have beneficial effects on eradication and therapy-related side effects, particularly diarrhea, in children.

Indexed as

AdolescentAnti-Bacterial AgentsAnti-Ulcer AgentsChildChild, PreschoolDrug Therapy, CombinationGastritisHelicobacter InfectionsHelicobacter pyloriHumansInfantOdds RatioProbioticsRandomized Controlled Trials as TopicTreatment OutcomeAnti-Bacterial AgentsAnti-Ulcer Agents

Identifiers

PMID24323343
OpenAlexW2051952053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.